YouTube Facebook LinkedIn Google+ Twitter Xingrss  

GNS Healthcare to Mine Data in MS Drug Development Alliance

March 4, 2013 |  GNS Healthcare has joined in the formation of Orion Bionetworks, a new alliance to accelerate the drug development process for a wide variety of diseases, beginning with multiple sclerosis (MS). Using patient data from alliance members Accelerated Cure Project for Multiple Sclerosis, the Institute for Neurosciences at Brigham and Women’s Hospital, and PatientsLikeMe, GNS will build powerful, predictive, computational models to yield new information about the disease, which will pave the way for more effective treatments for patients and the discovery of new therapies and cures. The initial phase of this effort is made possible by a $5.4 million commitment by Janssen Research & Development, a subsidiary of Johnson & Johnson. GNS Healthcare
Click here to log in.


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 ,